New mouse models can bridge gap in Alzheimer’s research
On Apr. 7, 2025, in a landmark study, researchers at University of Nebraska Medical Center (UNMC) announced they…
New CDKL genes linked to neurodevelopmental disorders
On Apr. 3, 2025, a team led by researchers at Baylor College of Medicine and the Jan and…
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Measles | Medicine | Neurology | NIH | Oncology | Organ Transplant | Pharmaceutical | Plague | Polio | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
HHS starts layoffs of thousands of workers across its agencies
On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…
CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and Development
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Agriculture | Artificial Intelligence | Biotechnology | CDC | Cloning | Diagnostics | HIV | Infectious Disease | Nanotechnology | Neurology | NIH | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | USDA | Vaccine | WHO | Women's Health
75% of U.S. scientists who answered Nature poll consider leaving
On Mar. 27, 2025, a Nature survey of more than 1,200 scientists, three-quarters of the total respondents are…
Atlas of Brain’s Mitochondria Reveals High Cognition Areas Supplied with More Energy
On Mar. 26, 2025, researchers from Columbia University announced they have created MitoBrainMap, the first-ever atlas of the…
Paralysed man stands again after receiving ‘reprogrammed’ stem cells
On Mar. 24, 2025, Hideyuki Okano, a stem-cell scientist at Keio University in Tokyo, and his colleagues announced…
Scientists solve decades-long Parkinson’s mystery
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
Biotechnology | Disease | FDA | Medicine | Neurology | Therapeutics
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
On Mar. 3, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase),…
CDC Reports Encephalopathy Among Children with Influenza-Associated Mortality
On Feb. 27, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced that it is investigating…
Child ADHD risk linked to mother’s use of acetaminophen
On Feb. 20, 2025, researchers from the University of Washington and Seattle Children’s Research Institute announced findings from…
Next-gen Alzheimer’s drugs extend independent living by months
On Feb. 13, 2025, researchers at Washington University School of Medicine in St. Louis announced a new analysis…
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy
On Feb. 12, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved a New…
man destined for early Alzheimer’s Survived More Than Twenty Years longer than expected
On Feb. 10, 2025, scientists announced identifying genetic variants that could have helped a man to avoid dementia…
Scientists Identify Alzheimer’s Disease-Protective Genetic Factors and Unravel Disease Mechanisms
On Feb. 4, 2025, an international research teams led by Hong Kong University of Science and Technology (HKUST)…
Biotechnology | Disease | FDA | Neurology | Ophthalmogy | Therapeutics
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
On Feb. 4, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Susvimo® (ranibizumab…
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
On Jan. 30, 2025, the California Institute for Regenerative Medicine (CIRM) announced it has awarded nearly $100 million…
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
On Jan. 30, 2025, the U.S. Food and Drug Administration (FDA) approved Vertex Pharmaceuticals’s Journavx (suzetrigine) 50 milligram…
Bacteria found to eat forever chemicals — and even some of their toxic byproducts
On Jan. 27, 2025, a team of researchers from the University of Buffalo found that In the quest…
Biotechnology | Diagnostics | Disease | FDA | Medicine | Neurology | NIH | Oncology | Therapeutics | U.S. Congress | Vaccine | Women's Health
U.S. FDA drops Support improving clinical trial diversity
Jan. 24, 2025, the U.S. Food and Drug Administration (FDA) pulled draft guidance from its website requiring companies…
SIDS Discovery Could ID Babies at Risk
On Jan. 22, 2025, researchers from the University of Virginia School of Medicine reported revealing the fingerprints of…
FDA approved SPRAVATO® (esketamine) in the U.S. as the first and only monotherapy for adults with treatment-resistant depression
On Jan. 21, 2025, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of a…
Artificial Intelligence | Biotechnology | Medical Device | Medicine | Nanotechnology | Neurology | Therapeutics
Rice labs tapped for brain research by UK funding agency with multimillion-dollar awards
On Jan. 21, 2025, Rice University announced that four research groups are part of an inaugural cohort of…
Agriculture | Chemical | Diagnostics | HIV | Infectious Disease | Neurology | NIH | Non-Profit Research | Therapeutics
HIV vaccines can lead to Chain Reaction of antibodies against antibodies
On Jan. 17, 2025, scientists from Scripps Research Institute reported finding that some HIV vaccination can lead to…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
Study pinpoints depression genes across ethnicities
On Jan. 14, 2025, an international research team led by the University of Edinburgh reported new genetic risk…
United States Dementia Cases Estimated to Double by 2060
On Jan. 13, 2025, a study led by NYU Langone Health shows that the risk of developing dementia at…
Research Highlights Trends in ADHD Diagnoses
On Jan. 13, 2025, new research identifies differing trends in attention-deficit/hyperactivity disorder (ADHD) diagnoses among adolescents and adults,…
Hunters Disagree on the Threat of Chronic Wasting Disease in Deer
On Jan. 10, 2025, a study of chronic wasting disease (CDW), the prion disease that causes deer, elk…
Biotechnology | Diagnostics | Disease | FDA | Neurology
FDA Issues Final Guidance for Industry on Action Levels for Lead in Processed Food for Babies and Young Children
On Jan. 6, 2025, the U.S. Food and Drug Administration (FDA) issued guidance for industry on the action…
Agriculture | Chemical | Diagnostics | Disease | Neurology | NIH | Non-Profit Research | Therapeutics
Scripps Research uses Virtual chemistry to speed up drug discovery
On Jan. 3, 2025, scientists from Scripps Research reported that by using computer modeling to predict chemical reactions,…